Clinical Trial

Study of Oral Food Challenge Biomarkers (SAFER)

Study acronym: SAFER
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This is a multi-center, mechanistic study. It is designed to learn more about signs in the body, called biomarkers, that might show if someone will have a reaction to peanut during a feeding test. The trial will enroll children ages 12 months to17 years old who are suspected of having an allergy to peanut. The primary objective is to identify a biomarker (or a combination of biomarkers) that will predict oral food challenge (OFC) (feeding test) results for participants with suspected peanut allergy.
Trial Details
NCT Number NCT07279467
Lead Sponsor National Institute of Allergy and Infectious Diseases (NIAID)
Collaborators: Consortia for Food Allergy Research (CoFAR), Rho Federal Systems Division, Inc.
Conditions Allergy
Enrollment 500 participants
Start Date 2026-04
Primary Completion 2027-10-01 (estimated)
Study Completion 2027-10-01 (estimated)
Updated on ClinicalTrials.gov 2025-12-12